h25
Conditions
Interventions
Group 1: The study design is retrospective and controlled. The study will be done at a single center. Patient will be examined at only a single visit.
Up to 100 subjects already implanted with a HOYA
Sponsors
Hoya Surgical Optics
Eligibility
Sex/Gender
All
Age
22 Years to No maximum
Inclusion criteria
Inclusion criteria: • Patients implanted with IOL • Minimum 22 years of age • Available and comply to study procedures • Ability and willingness to sign informed consent
Exclusion criteria
Exclusion criteria: • Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with the fluctuation of hormones that could lead to refractive changes • Concurrent participation or participation within 30 days prior to preoperative visit in any other clinical trial with an investigational product
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Distance corrected visual acuity measured at single postoperative visit, using visual acuity charts at a minimum of 4 meter | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Device related adverse events (ADEs and SADEs) 2. Subjective grading of glistening 3. Optical/ visual symptoms | — |
Countries
Germany
Contacts
Public ContactGerd Auffahrt
Universitäts-Augenklinik
Outcome results
None listed